The company said it needed to raise the money to keep up with demand. Accuri launched its Accuri C6 Flow Cytometer in April 2008 and followed that launch three months later with a $13 million raise to expand its marketing and sales efforts of the product.
CoAxia thinks its NeuroFlo technology could be part of basic care for 500,000 ischemic stroke patients, breaking into a market worth more than $1 billion. Instead of attacking the brain clot, its catheter diverts blood flow from the lower parts of the body and pushes it into the brain to increase blood flow.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.